Spouting Rock Asset Management, LLC Ligand Pharmaceuticals Inc Transaction History

Spouting Rock Asset Management, LLC

  • $273 Million
  • Q4 2023

A detailed history of Spouting Rock Asset Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Spouting Rock Asset Management, LLC holds 3,445 shares of LGND stock, worth $394,934. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,445
Previous 9,219 62.63%
Holding current value
$394,934
Previous $552,000 55.43%
% of portfolio
0.09%
Previous 0.18%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 16, 2024
SELL
$49.57 - $72.63 $286,217 - $419,365
-5,774 Reduced 62.63%
3,445 $246,000
Q1 2023

May 10, 2023
BUY
$65.67 - $77.08 $605,411 - $710,600
9,219 New
9,219 $678,000
Q3 2022

Nov 08, 2022
BUY
$0.01 - $107.56 $26 - $284,603
2,646 New
2,646 $228,000
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $149,312 - $205,600
-1,321 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$99.52 - $215.83 $131,465 - $285,111
1,321 New
1,321 $201,000
Q4 2020

Feb 11, 2021
SELL
$80.55 - $106.05 $1.36 Million - $1.79 Million
-16,887 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$89.56 - $126.72 $213,331 - $301,847
2,382 Added 16.42%
16,887 $1.61 Million
Q2 2020

Aug 03, 2020
BUY
$68.28 - $123.65 $262,468 - $475,310
3,844 Added 36.06%
14,505 $1.62 Million
Q1 2020

Jun 11, 2020
SELL
$63.37 - $107.88 $272,681 - $464,207
-4,303 Reduced 28.76%
10,661 $775,000
Q4 2019

May 14, 2020
BUY
$96.94 - $113.59 $1.45 Million - $1.7 Million
14,964 New
14,964 $1.56 Million

Others Institutions Holding LGND

# of Institutions
256
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email